drugset / Trial / NCT02548611

Comparison of Loading Strategies With Antiplatelet Drugs in Patients Undergoing Elective Coronary Intervention

NCT02548611 ↗

Phase 4 Terminated 795 enrolled LMU Klinikum
RandomizedParallel-groupSingle-blindTreatment

Summary

Use of high loading doses of clopidogrel (antiplatelet drug) just before coronary interventions is associated with improved outcomes after coronary stenting. However the onset of platelet inhibition after clopidogrel loading takes 2 to 4 hours and its action if very variable. A way to overcome this limitation is loading with a more potent antiplatelet drug such as prasugrel. Therefore in the current study the investigators want to compare loading with 60 mg prasugrel (potent antiplatelet drug) and loading with clopidogrel (standard drug) in patients undergoing elective coronary intervention.

Timeline

Start
2015-09
Primary completion
2018-08
Completion
2018-11

Outcome

Missed primary endpoint

Stopped (Enrollment): “Due to low recruitment”

paper odds ratio, 0.92 [95% CI, 0.63-1.32]; P=0.64 PMID 32527192 ↗

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clopidogrel Small molecule 600 mg —
Subject Prasugrel Small molecule 60 mg —